These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25217162)

  • 1. Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection.
    Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Roy S
    J Immunol; 2014 Oct; 193(8):4083-94. PubMed ID: 25217162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimony-Resistant Leishmania donovani Exploits miR-466i To Deactivate Host MyD88 for Regulating IL-10/IL-12 Levels during Early Hours of Infection.
    Mukherjee B; Paul J; Mukherjee S; Mukhopadhyay R; Das S; Naskar K; Sundar S; Dujardin JC; Saha B; Roy S
    J Immunol; 2015 Sep; 195(6):2731-42. PubMed ID: 26283478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation.
    Haldar AK; Yadav V; Singhal E; Bisht KK; Singh A; Bhaumik S; Basu R; Sen P; Roy S
    PLoS Pathog; 2010 May; 6(5):e1000907. PubMed ID: 20502630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1.
    Mukherjee B; Mukhopadhyay R; Bannerjee B; Chowdhury S; Mukherjee S; Naskar K; Allam US; Chakravortty D; Sundar S; Dujardin JC; Roy S
    Proc Natl Acad Sci U S A; 2013 Feb; 110(7):E575-82. PubMed ID: 23341611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sub-optimal dose of Sodium Antimony Gluconate (SAG)-diperoxovanadate combination clears organ parasites from BALB/c mice infected with antimony resistant Leishmania donovani by expanding antileishmanial T-cell repertoire and increasing IFN-gamma to IL-10 ratio.
    Haldar AK; Banerjee S; Naskar K; Kalita D; Islam NS; Roy S
    Exp Parasitol; 2009 Jun; 122(2):145-54. PubMed ID: 19422069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant
    Mukherjee S; Pradhan S; Ghosh S; Sundar S; Das S; Mukherjee B; Roy S
    Front Cell Infect Microbiol; 2020; 10():595415. PubMed ID: 33240825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
    Bimal S; Sinha S; Singh SK; Narayan S; Kumar V; Verma N; Ranjan A; Sinha PK; Das VN; Pandey K; Kar SK; Das P
    Exp Parasitol; 2012 Jul; 131(3):274-82. PubMed ID: 22580024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
    Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
    Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection.
    Mookerjee Basu J; Mookerjee A; Banerjee R; Saha M; Singh S; Naskar K; Tripathy G; Sinha PK; Pandey K; Sundar S; Bimal S; Das PK; Choudhuri SK; Roy S
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1080-93. PubMed ID: 18056276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipramine is an orally active drug against both antimony sensitive and resistant Leishmania donovani clinical isolates in experimental infection.
    Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Das AK; Roy S
    PLoS Negl Trop Dis; 2012; 6(12):e1987. PubMed ID: 23301108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-β in early immune response.
    Guha R; Das S; Ghosh J; Sundar S; Dujardin JC; Roy S
    PLoS Negl Trop Dis; 2014 Jul; 8(7):e2995. PubMed ID: 25032977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.
    Mukhopadhyay R; Mukherjee S; Mukherjee B; Naskar K; Mondal D; Decuypere S; Ostyn B; Prajapati VK; Sundar S; Dujardin JC; Roy S
    Int J Parasitol; 2011 Nov; 41(13-14):1311-21. PubMed ID: 21920365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis.
    Bhattacharjee A; Majumder S; Majumdar SB; Choudhuri SK; Roy S; Majumdar S
    Int J Antimicrob Agents; 2015 Mar; 45(3):268-77. PubMed ID: 25600891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB/c mice.
    Joshi J; Kaur S
    Parasitology; 2014 Apr; 141(4):554-62. PubMed ID: 24618257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance.
    Bhandari V; Kumar D; Verma S; Srividya G; Negi NS; Singh R; Salotra P
    Biochem Biophys Res Commun; 2013 Nov; 440(4):646-51. PubMed ID: 24103752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the molecular mechanism of aggressive infection by antimony resistant Leishmania donovani.
    Mukherjee B; Mukherjee K; Nanda P; Mukhopadhayay R; Ravichandiran V; Bhattacharyya SN; Roy S
    Cytokine; 2021 Sep; 145():155245. PubMed ID: 32861564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy.
    Carter KC; Hutchison S; Boitelle A; Murray HW; Sundar S; Mullen AB
    Parasitology; 2005 Dec; 131(Pt 6):747-57. PubMed ID: 16336728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
    Pal S; Mandal A; Duttagupta S
    Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR mediated GSK3β activation suppresses CREB mediated IL-10 production to induce a protective immune response against murine visceral leishmaniasis.
    Paul J; Naskar K; Chowdhury S; Chakraborti T; De T
    Biochimie; 2014 Dec; 107 Pt B():235-46. PubMed ID: 25223889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous interleukin-18 is involved in immunity to Leishmania donovani but its absence does not adversely influence the therapeutic activity of sodium stibogluconate.
    Mullen AB; Lawrence CE; McFarlane E; Wei XQ; Carter KC
    Immunology; 2006 Nov; 119(3):348-54. PubMed ID: 16879623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.